EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli

Silvia Galvan, Ana P Teixeira, Martin Fussenegger

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28770 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology and Bioengineering, 2024. Verfasst von Silvia Galvan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Synthetic Biology, Gene Regulatory Networks. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic biology aims to contribute to the development of next‐generation patient‐specific cell‐based therapies for chronic diseases especially through the construction of sophisticated synthetic gene switches to enhance the safety and spatiotemporal controllability of engineered cells. Indeed, switches that sense and process specific cues, which may be either externally administered triggers or endogenous disease‐associated molecules, have emerged as powerful tools for programming and fine‐tuning therapeutic outputs. Living engineered cells, often referred to as designer cells, incorporating such switches are delivered to patients either as encapsulated cell implants or by infusion, as in the case of the clinically approved CAR‐T cell therapies. Here, we review recent developments in synthetic gene switches responsive to molecular stimuli, spanning regulatory mechanisms acting at the transcriptional, translational, and posttranslational levels. We also discuss current challenges facing clinical translation of cell‐based therapies employing these devices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell- and Tissue-Based TherapySynthetic BiologyGene Regulatory NetworksHumansGenes, SyntheticAnimals

Stichwörter der Autor:innen

cell therapiesdesigner cellsgenetic switchesmammalian cell engineeringsynthetic biology

Autor:innen und Institutionen

  • Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
  • Faculty of Science, University of Basel, Basel, Switzerland.

Förderung

  • European Research Council

Zitieren

APA

Galvan, S., Teixeira, A. P., & Fussenegger, M. (2024). Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28770

Vancouver

Galvan S, Teixeira AP, Fussenegger M. Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28770

BibTeX
@article{Galvan2024,
  author = {Galvan, Silvia and Teixeira, Ana P and Fussenegger, Martin},
  title = {Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28770}
}
Kostenlos starten →